Finance

Beta
Lists
4TZ:FRA
ORIC Pharmaceuticals Inc
€6,79
-5,01%
(-0,36) 1D
2 Jun., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4TZ...
Open
€6,91
High
€6,91
Low
€6,79
Mkt. cap
788,80 m
Avg. vol.
3,00
Volume
0,00
52-wk high
€13,30
52-wk low
€6,10
No. of employees
104
Open
€6,91
High
€6,91
Low
€6,79
Mkt. cap
788,80 m
Avg. vol.
3,00
Volume
0,00
52-wk high
€13,30
52-wk low
€6,10
No. of employees
104
News stories
From sources across the web
About ORIC Pharmaceuticals Inc
CEO-
Employees104
Founded2014
HeadquartersSouth San Francisco, Kalifornië, Verenigde State van Amerika
Sector-
Websiteoricpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
30,55 m
28,77 m
25,86 m
31,44 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,52 m
7,90 m
8,70 m
8,18 m
Operating expense
39,06 m
36,67 m
34,55 m
39,62 m
Total operating expenses
39,06 m
36,67 m
34,55 m
39,62 m
Operating income
-39,06 m
-36,67 m
-34,55 m
-39,62 m
Other non operating income
-
-
-
-
EBT including unusual items
-36,36 m
-32,59 m
-30,50 m
-35,77 m
EBT excluding unusual items
-36,36 m
-32,59 m
-30,50 m
-35,77 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-36,36 m
-32,59 m
-30,50 m
-35,77 m
Net profit margin
-
-
-
-
Earnings per share
-0,47
-0,33
-0,30
-0,34
Interest and investment income
2,71 m
4,08 m
4,05 m
3,85 m
Interest expense
-
-
-
-
Net interest expenses
2,71 m
4,08 m
4,05 m
3,85 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-38,75 m
-36,38 m
-34,23 m
-39,35 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer